Table 7.
Baseline Correlates of BeingSexually Active among Female Participants with Chronic Kidney Disease§ (for unadjusted and adjusted logistic regression analyses)
| Unadjusted Model n=198 |
Adjusted Model 1 n=198 |
Adjusted Model 2 n=197 |
Adjusted Model 3 n=195 |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Characteristic | Odds Ratio | 95% CI | Odds Ratio | 95% CI | Odds Ratio | 95% CI | Odds Ratio | 95% CI | |
| Unadjusted Model | |||||||||
| Systolic blood pressure (mmHg) | 0.967 | (0.94,0.99) | 0.988 | (0.96,1.02) | 0.983 | (0.95,1.02) | 0.977 | (0.94,1.01) | |
| Diastolic blood pressure (mmHg) | 1.025 | (0.99,1.06) | 0.988 | 90.95,1.03) | 0.982 | (0.94,1.03) | 0.986 | (0.94,1.04) | |
| Demographic Variables (Adjusted Model 1) | |||||||||
| Age (yrs). | --- | --- | 0.924 | (0.87,0.98) | 0.927 | (0.87,0.98) | 0.917 | (0.86,0.98) | |
| African-American vs. White | --- | --- | 0.606 | (0.25,1.49) | 0.645 | 0.23,1.82) | 0.637 | (0.20,2.00) | |
| Other vs. White | --- | --- | 0.427 | (0.08,2.33) | 0.511 | (0.09,2.94) | 0.446 | (0.07,2.93) | |
| < High school vs. College Graduate | --- | --- | 0.363 | (0.09,1.44) | 0.397 | (0.08,1.91) | 0.387 | (0.07,2.29) | |
| High School graduate/GED vs. College Graduate | --- | --- | 0.476 | (0.15,1.48) | 0.451 | (0.13,1.53) | 0.389 | (0.10,1.55) | |
| Post High School vs. College Graduate | --- | --- | 0.908 | (0.36,2.29) | 0.869 | (0.31,2.42) | 0.823 | (0.28,2.38) | |
| Lives alone vs. Lives with Others | --- | --- | 0.286 | (0.11,0.76) | 0.200 | (0.07,0.60) | 0.197 | (0.07,0.60) | |
|
Behavioral Risk Factor and Medication Use Variables (Adjusted Model 2) |
|||||||||
| Alcohol Consumption (drinks/typ wk) | --- | --- | --- | --- | 1.512 | (1.02,2.24) | 1.560 | (1.04,2.34) | |
| Beta-blockers (BB) vs. no BB | --- | --- | --- | --- | 1.418 | (0.61,3.28) | 1.532 | (0.65,3.61) | |
| Diuretics vs. no diuretics | --- | --- | --- | --- | 0.283 | (0.12,0.70) | 0.329 | (0.13,0.86) | |
| Calcium channel blockers vs.no calcium channel blockers |
--- | --- | --- | --- | 1.677 | (0.67,4.18) | 1.539 | (0.60,3.95) | |
| Angiotensin Converting Enzyme (ACE) inhibitors vs. no ACE |
0.818 | (0.31,2.18) | 0.926 | (0.33,2.57) | |||||
| Angiotensin receptor blockers (ARB) vs. no ARB | --- | --- | --- | --- | 1.017 | (0.35,3.00) | 1.091 | (0.35,3.36) | |
| Any Cholesterol Medication | --- | --- | --- | --- | 1.204 | (0.50,2.90) | 1.199 | (0.47,3.05) | |
|
Cardiometabolic and Psychosocial Variables (Adjusted Model 3) |
|||||||||
| BMI (kg/m2) | --- | --- | --- | --- | --- | --- | 0.950 | (0.88,1.02) | |
| eGFR (mL/min/1.73 m2) | --- | --- | --- | --- | --- | --- | 0.990 | (0.95,1.04) | |
| MoCA scorea | --- | --- | --- | --- | --- | --- | 0.972 | (0.86,1.10) | |
| PHQ-9 Total Scoreb | --- | --- | --- | --- | --- | --- | 0.978 | (0.87,1.10) | |
| Number of Physical Comorbiditiesb | --- | --- | --- | --- | --- | --- | 0.951 | (0.78,1.16) | |
§
defined as estimated glomerular filtration rate of <60 mL/min/1.73m2)
--- variable not included in model
a
Higher scores indicate better function
b
Higher scores indicate poorer function significant (p<0.05) Adjusted Odds Ratios and 95% Confidence Intervals presented in bold